Alcami Announces Deal with New Investors
Madison Dearborn Partners will acquire a majority ownership position in CDMO Alcami.
Alcami Corporation announced in a June 1, 2018 press statement that Madison Dearborn Partners, LLC (MDP), a private equity firm based in Chicago, will acquire a majority ownership position in Alcami from existing shareholder Ares Capital Corporation.
The Durham, NC-based contract development and manufacturing firm has 10 locations worldwide and provides API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, drug product manufacturing, and packaging and stability services tailored to small and mid-size pharmaceutical and biotechnology companies.
The current Alcami's management team, led by Chief Executive Officer, President, and Chairman, Stephan Kutzer, will continue with the company. The company expects the transaction to be completed in the third quarter of 2018, pending customary closing conditions.
"The entire Alcami team is excited to further enhance and evolve the small to mid-size pharma growth engine. As we enter our next stage of progress as a leading global, clinically-focused and fully-integrated contract development and manufacturing organization, we are proud to partner with MDP to expand our talented employee base and further develop our capabilities," said Kutzer in the press release.
Source: Alcami
Tokyo University of Science Research Team Explores Improved Delivery of Antisense Oligonucleotides
April 18th 2025Using cholesterol-modified oligonucleotides, the research team aims to improve the delivery of antisense nucleotide-based therapies for treating neurodegenerative diseases and brain cancers.
